Schedule M - Summary (Drugs and Cosmetics Rules, India)
Purpose
Schedule M ensures that drugs manufactured in India are safe, effective, and of standard quality. It lays out Good
Manufacturing Practices (GMP) and requirements for manufacturing premises, equipment, and procedures.
Major Components
- General Requirements: Clean location, proper building design, ventilation, and lighting.
- Plant and Equipment: Proper design, materials, and segregation of activities.
- Personnel: Qualified staff, trained in GMP.
- Sanitation and Hygiene: Regular cleaning and hygiene protocols.
- Documentation: Records of manufacturing, testing, distribution, and recalls.
- Quality Control: Independent QC department, sampling and testing.
- Storage: Proper conditions and segregation.
- Validation: Processes, equipment, and cleaning methods.
- Self-Inspection: Internal audits and CAPA.
- Dosage Form Guidelines: Specific norms for tablets, injections, ointments, etc.
Annexures
- Annexure I: Equipment requirements for dosage forms
- Annexure II: List of SOPs and documents
- Annexure III: Glossary of GMP terms
Recent Amendments
The latest amendments (2023-2024) align with international GMP like WHO-GMP and EU-GMP, focusing on data
integrity, quality risk management, computerized systems, and stricter environmental controls.
Comparison with Pharmacy Act
Pharmacy Act, 1948 governs pharmacists' education and registration.
Schedule M under the Drugs and Cosmetics Rules governs pharmaceutical manufacturing practices.